News - Page 30 of 36 - MaRS Innovation

Shotlst CEO featured in Globe article on future of tech in education

Matt Ratto, assistant professor in the University of Toronto's Faculty of Information and co-inventor and CEO of Shotlst, a UTEST company, was featured in the Globe and Mail on October 22 in an article by Nick Rockel on how emerging technology will change the education experience. Here's an excerpt: Asked what the technological tools in university classrooms will look and feel like by 2020, Matt Ratto admits he’s no futurist. But the assistant professor at the University of Toronto’s Faculty of Information is ... Read more

We’ve refreshed our website: Beta version now live

Welcome to the beta version of the MaRS Innovation website. We have refreshed the site's design to make better use of its existing functionality while  showcasing our projects. The new design includes these additions and changes: (more…) Read more

Baxter and MaRS Innovation Form Strategic Partnership

Partnership to invest up to $1M in promising Canadian healthcare discoveries TORONTO, Ontario, October 4, 2012—Baxter International Inc. and MaRS Innovation, a Centre of Excellence for Commercialization and Research, have entered into a strategic partnership to commercialize early-stage technologies that present innovative methods in therapeutics and drug discovery technologies. Information about Baxter and MaRS Innovation's partnership is also available in French. The partnership’s shared vision for delivering novel, transformative therapeutic technologies will benefit Canadians and others around the world. Baxter and MaRS Innovation will ... Read more

Baxter et MaRS Innovation forment un partenariat stratégique

Un partenariat visant à investir jusqu’à 1 M$ dans les découvertes canadiennes prometteuses en matière de soins de santé TORONTO (Ontario), le 4 octobre 2012 – Baxter International Inc. et MaRS Innovation, un centre d’excellence en commercialisation et en recherche, ont établi un partenariat stratégique afin de commercialiser des technologies en phase de développement qui constituent des méthodes novatrices sur le plan des technologies thérapeutiques et de découverte de médicaments. Information about MaRS Innovation and Baxter's partnership is also available in English. (more…) Read more

ClevrU partners with Schulich School of Business professors to target online education market

MaRS Innovation and York University’s commercialization office support new partnership In the age of ITunes, videotaping lectures or converting existing textbooks into e-books won’t make you the market leader in online education. Thanks to a new partnership between ClevrU, and NewMindsets Inc., facilitated by MaRS Innovation and York University’s commercialization office, Canadian technology and content promises to establish the second-generation online learning standard for millions of students worldwide. (more…) Read more

U of T, MaRS Innovation Collaborate to Launch Incubator for Student Software Companies

TORONTO, ON – A new program that provides nascent software companies with start-up funds, work space, mentoring and business strategy support, was launched today by the University of Toronto and commercialization partner MaRS Innovation, with support from the MaRS Discovery District. TechVibes has a profile page for UTEST and covered CoursePeer as part of their students start-ups series. The new program, called University of Toronto Early Stage Technology (UTEST), is part of a growing ecosystem of incubators and commercialization support services at U ... Read more

Business Without Borders highlights ScarX Therapeutics’ Chinese co-development partnership

ScarX Therapeutics, a spin-off company created by MaRS Innovation and The Hospital for Sick Children (SickKids), was profiled by Business Without Borders on September 25, 2012. Sean Fine's article examines the strategic funding partnership MI pursued with NovoTek Therapeutics Inc. (NovoTek) in China to develop the anti-scarring cream, which was discovered by researchers at SickKids. A multibillion-dollar market may await ScarX, a Toronto biomedical start-up, but first it had to figure out how to finance the development of its unique cream that reduces scarring ... Read more

VP Joel Liederman’s Financial Post article on mitigating innovation risk

MaRS Innovation's Vice-President of Business Development and Physical Sciences Joel Liederman, has published an article in the Financial Post about strategies to mitigate risk within the innovation space. The article, titled "Innovation Success Means Mitigating Risk," is featured in the newspaper's Productive Conversations section. (more…) Read more

BioCentury features Encycle Therapeutics and MaRS Innovation in macrocycle chemistry article

Encycle Therapeutics, a MaRS Innovation spin-off company, was included in BioCentury's companies to watch within the macrocycle chemistry space. The reference came in Chris Cain's article, "Maturing macrocycle chemistry drives explosion of biotech newcos, biopharma deals." (more…) Read more

CML HealthCare Inc. and MaRS Innovation Enter into Strategic Partnership

MISSISSAUGA, Ontario, September 18, 2012 – CML HealthCare Inc. (TSX: CLC) (the “Company” or “CML”) and MaRS Innovation (MI), a Centre of Excellence for Commercialization and Research, have entered into a strategic partnership to commercialize early-stage technologies that present innovative methods in medical diagnostics. This story was covered in the Globe and Mail, Canadian Business, 680 News, Reuters, Sympatico.ca, the Huffington Post Canada, Technology Trasnfer Tactics, and the Winnipeg Free Press, among others. It was  distributed via Yahoo! Finance, Healthcare Global.com, marketwire ... Read more
Page 30 of 36« First...1020...2829303132...Last »